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Abstract.  The differentiated phenotype of rabbit artic- 
ular chondrocytes was modulated in primary culture 
by treatment with 1 pg/ml retinoic acid (RA) and 
reexpressed in secondary culture by treatment with the 
microfilament-disruptive drug dihydrocytochalasin B 
(DHCB) in the absence of RA. Because the effective 
dose of DHCB (3  ~tM) did not elicit detectable cell 
rounding or retraction, the nature and extent of 
microfilament modification responsible for induction of 
reexpression was evaluated.  The network of microfila- 
ment stress  fibers  detected with rhodamine-labeled 
phalloidin in primary control chondrocytes was altered 
by RA to a "cobblestone" pattern of circularly oriented 
fibers  at the cell periphery. Subsequent treatment with 
DHCB resulted in rapid changes in this pattern before 
overt reexpression. Stress  fibers  decreased in number 
and were reoriented. Parallel  arrays of long fibers  that 
traversed  the cell were evident, in addition to fiber 
fragments and focal condensations of staining. Im- 
munofluorescent staining of intermediate filaments re- 
vealed a marked decrease in complexity and intensity 
during RA treatment but no change during reexpres- 
sion. An extended microtubular architecture was pres- 
ent throughout the study. These results clearly identify 
microfilaments as the principal affected cytoskeletal 
element and demonstrate that their modification, rather 
than complete disruption, is sufficient for reexpres- 
sion. The specificity of DHCB and the reorientation of 
these filaments before reexpression of the differentiated 
phenotype suggests a causative role in the mechanism 
of reexpression. 
C 
HONDROCYTES exhibit high levels of synthesis of car- 
tilage-specific proteoglycan and type II collagen as a 
major part of their differentiated phenotype. The ex- 
pression of this phenotype has been shown to be responsive 
to changes in cell shape, the maintenance (13) or resumption 
(5) of spherical conformation promoting the expression of 
the differentiated phenotype. In contrast modulating agents 
such  as  fibronectin  (17, 26)  and retinoic  acid  (RA) t  (4), 
which appear to enhance both adhesion and spreading of  cul- 
tured chondrocytes, also enhance the rate at which the differ- 
entiated phenotype is lost. These observations, together with 
the results of more recent studies on the effects of microfila- 
ment-modifying drugs on chondrogenesis  (18, 27), suggest 
the involvement of some element of the cytoskeleton in mod- 
ulation of the chondrocyte phenotype. 
To study this involvement, the cytoskeletal architecture of 
rabbit articular chondrocytes has been examined by immu- 
nofluorescent techniques during both RA modulation of the 
differentiated phenotype and its subsequent reexpression as 
1. Abbreviations  used in this paper:  DHCB, dihydrocytochalasin B; RA, 
retinoic acid. 
induced by the microfilament-modifying drug dihydrocyto- 
chalasin B (DHCB).  Transitions in the synthesis of geneti- 
cally distinct collagen types were used as markers for defined 
phenotypic change, and are reported separately (4, 6). Briefly, 
RA modulation of the phenotype was marked by a cessation 
of type II collagen synthesis and a transient stimulation of 
type III and type I trimer synthesis. DHCB-induced  reex- 
pression of  the differentiated phenotype was marked by a loss 
of type III and type I trimer synthesis and a return of type 
II synthesis. Notably this induction of reexpression did not 
involve a resumption of spherical cell shape; rather the cells 
remained as a well-spread confluent monolayer. 
The purpose of this study was to determine the rate and 
extent of microfilament modification responsible for the ini- 
tiation  of phenotypic  reexpression  in the absence  of cell 
rounding, and to evaluate the extent to which other cytoskele- 
tal structures might be involved. We report here that both RA 
modulation  and  DHCB-induced  reexpression  resulted  in 
marked microfilament modification, and modification caused 
by DHCB preceded the resumption of type II collagen syn- 
thesis. The organization of  intermediate filaments and micro- 
tubules appeared to be largely independent of these changes. 
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Cell Culture 
Chondrocyte monolayer cultures were established from the articular carti- 
lage of the humeral head of 8-wk-old New Zealand White rabbits and grown 
in medium containing 10% FBS as previously described (6). After 10 d of 
culture in the absence or presence of 1 lag/ml RA (Sigma Chemical Co., 
St.  Louis, MO), control and RA-modulated cells were replated at 4.0  ￿ 
I(P cells/cm  z as secondary cultures grown in plastic chamber slides (Miles 
Laboratories Inc., Naperville, IL). Cells were allowed to attach for 4 d  in 
the absence or presence of RA. 
RA was then removed from treated cultures to begin the reexpression 
period. These cells were maintained in 2 or 10% FBS in the absence or pres- 
ence of DHCB (3  x  10  -6 M) (Sigma Chemical Co.) from day 4 to day 18 
of secondary culture. Cells were examined by immunofluorescence 1, 2, 7, 
and  14 d after the removal of RA. 
Immunofluorescence Microscopy 
Microfilament-containing stress fibers were stained with rhodamine-labeled 
phalloidin  (Molecular  Probes  Inc.,  Junction City,  OR).  The cells were 
rinsed  briefly  in  calcium and  magnesium-free Dulbecco's  PBS  (Gibeo, 
Grand Island, NY) containing 5 mM EGTA, and then fixed in 4% (wt/vol) 
paraformaldehyde in PBS-EGq'A for 20 min at 37~  The cells were then 
immersed in 47.5% ethanol, containing 5 mM EGTA, for 15 min at room 
temperature and finally held in PBS-EGTA for 5 rain before staining (14). 
The cells were stained with a 1:20 dilution of rhodamine phalloidin in PBS- 
EGTA for 30 min at 37~  The cells were then rinsed in several changes 
of PBS-EGTA and mounted in a  1:1 mix of glycerol and PBS-EGTA. 
Microtubules were stained using a  mouse mAb raised against native 
chick brain microtubules (Amersham Corp., Arlington Heights, IL).  All 
antibody and labeled streptavidin dilutions were made in PBS-EGTA con- 
taining 1 mg/ml BSA and 0.1%  (wt/vol) sodium azide. Cells were rinsed 
briefly with 60 mM Pipes buffer, pH 6.9, containing 25 mM Hepes, 10 mM 
EGTA, and 2  mM magnesium chloride, and then immersed in the same 
buffer containing 0.15%  (vol/vol) Triton X-100 for 2 min at room tempera- 
ture (19). Treatment with Triton X-100 removed many soluble proteins with- 
out altering the microtubule cytoskeletal network and resulted in increased 
clarity of the fluorescent image. After rinsing briefly in the initial buffer the 
cells were fixed in methanol containing 5 mM EGTA for 6 min at -20~ 
(16).  The cells were held in PBS-EGTA for 5  rain before staining with a 
1:500 dilution of the mAb for  1 h at 37~  and then rinsed three times in 
PBS-EGTA. The cells were then incubated for 1 h at 37~  with a  1:50 dilu- 
tion of biotinylated second antibody, raised against mouse Ig (Amersham 
Corp.), and rinsed three times in PBS-EGTA. Detection was carried out by 
incubation for 30 min at 37~  with a  1:50 dilution of Texas Red-labeled 
streptavidin (Amersham Corp.), the cells rinsed and mounted as described. 
Intermediate filaments were stained using a mouse mAb raised against 
porcine eye lens vimentin (Amersham  Corp.). Cells were fixed as described 
for microfilament staining with the exception that the paraformaldehyde so- 
lution contained 0.5 mg/ml Saponin (Sigma Chemical Co.). Incubation with 
first and second antibodies and detection with Texas Red-labeled strep- 
tavidin was as described for microtubule staining, however a  1:5 dilution 
of the monoclonal first antibody was used. 
The stained cells were viewed using a photomicroscope lit (Carl Zeiss 
Inc.,  Thornwood,  NY),  equipped with epifluorescent illumination and a 
filter suitable for rhodamine, Photomicrographs were taken using Tri-X-Pan 
ASA 400 film (Eastman Kodak Co.,  Rochester, NY). 
Results 
Preliminary studies with a variety of fixation procedures re- 
vealed that no single procedure gave optimum results with 
all  three  filament systems.  The different procedures used 
with each type of filament were selected or modified from 
existing procedures based on the criteria of integrity of struc- 
ture, continuity of filaments, and brightness and clarity of 
image. Microfilament-containing stress fibers stained in cells 
that had been fixed with methanol appeared faint and frag- 
mented or punctate. However the same fibers stained in cells 
fixed with paraformaldehyde, the procedure used routinely, 
appeared bright and continuous. In contrast smoothly curv- 
ing microtubules were only seen in cells fixed in methanol. 
At no time were the cells allowed to dry, because this dis- 
torted both the shape of  the cell and the orientation of  the fila- 
ments. 
Alterations in Microfilament Organization 
Treatment of primary rabbit chondrocytes with 1 ~g/ml RA 
resulted in loss of the differentiated chondrocyte phenotype 
and replacement by a  modulated phenotype. This was ac- 
companied by the  loss of the  polygonal morphology and 
colony forming capacity that are characteristic of  control pri- 
mary chondrocytes (4).  The RA-modulated  chondrocytes 
formed a uniform and continuous monolayer and showed no 
colony formation even after t4 d  of primary culture. This 
change in morphology was accompanied by a profound alter- 
ation  in  microfilament/stress  fiber  architecture.  The  un- 
oriented stress fiber pattern of control chondrocytes (Fig.  1 
a) was replaced by a more ordered array of fibers concen- 
trated at, and aligned with, the cell periphery. Cell bound- 
aries, often obscured in control cells, were also very distinct 
in RA-modulated chondrocytes (Fig. 1 b), a reflection of the 
marked contact inhibition of growth observed in these cul- 
tures. 
Reexpression of the differentiated phenotype was induced 
in secondary culture, following the removal of RA, by cul- 
ture in the presence of 3  x  10  -6 DHCB (6). After 7 d the 
pattern of stress fiber organization induced by RA had been 
lost (Fig.  1 c). The total number of fibers was significantly 
reduced and those that remained were aligned with the lon- 
gitudinal axis of the cell in a near parallel array. Focal con- 
densations of actin were also present in many of the cells. 
RA-modulated chondrocytes cultured for this period of time 
in the absence of RA and DHCB, maintained much of the 
RA-induced pattern of stress fiber organization. Cell bound- 
aries remained distinct and the fibers were still concentrated 
at the cell periphery (Fig.  1 d). 
By 14 d of culture in the presence of DHCB a further de- 
crease in the number of fibers was noticed, however some 
long fibers remained in alignment with the longitudinal axis 
and some overgrowth of cells was evident (Fig.  1 e); indeed 
phase contrast micrographs of these cells revealed limited 
colony formation (6). Cells cultured in the absence of DHCB 
for 14 d had lost much of the RA-induced pattern of stress 
fiber organization, and contact inhibition of growth was less 
marked (Fig.  1 f). However these cells still retained an ex- 
tensive, though more uniform, meshwork of stress fibers, 
and cell boundaries were still detectable. 
Alterations in Microtubule Organization 
In contrast to the microfilament/stress fiber network, the or- 
ganization of microtubules was largely unaffected by either 
RA or DHCB additions to the cultures. Both control (Fig. 
2 a) and RA-modulated chondrocytes (Fig. 2 b) were shown 
to contain extensive networks of these filaments. Again RA- 
modulated cells  showed  clearer  cell-cell  separation  than 
control cells. After 14 d of secondary culture in the presence 
of DHCB the cells still displayed a well-ordered and appar- 
ently intact microtubule cytoskeleton (Fig. 2 c), closely re- 
sembling that seen in cells cultured in the absence of DHCB 
(Fig. 2 d). This shows the integrity of the microtubule net- 
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were grown in primary and secondary culture in the absence (a) and presence (b) of RA. The RA-modulated cells were then cultured 
in the absence of RA and in the absence (d and f) and presence (c and e) of DHCB  for 7 (c and d) and 14 d (e and f). Bar, 20 I.tm. 
Brown and Benya Chondrocyte Cytoskeletal Architecture  173 Figure 2.  Immunofluorescent staining of microtubules in rabbit  chondrocytes.  Cells were grown in primary and secondary culture in the 
absence (a) and presence (b) of RA. The RA-modulated cells were then cultured in the absence of RA and in the absence (d) and presence 
(c) of DHCB for 14 d. RA-modulated cells were also cultured for 7 d in the absence of RA and  in the absence (e) and presence (f) of 
the microtubule disrupting  agent, colchicine. Bar,  20  ~tm. 
The Journal of Cell Biology,  Volume 106, 1988  174 Figure 3. Immunofluorescent staining of intermediate filaments in rabbit chondrocytes.  Cells were grown in primary and secondary culture 
in the absence (a) and presence (b) of RA. The RA-modulated cells were then cultured in the absence of RA and in the absence (d) and 
presence (c) of DHCB for 7 d. RA-modulated cells were also cultured for 2 d in the absence of RA and in the absence (e) and presence 
(f) of colchicine. Bar,  20 ~tm. 
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filament/stress  fiber organization.  This  independence has 
been  observed in  a  variety of other cell types including 
mouse  313  cells and  rat  mammary  fibroblasts (24).  The 
specificity of the  antibody  staining  of microtubules  was 
demonstrated by culture of the ceils in the presence of the 
microtubule  disrupting  agent,  colchicine.  RA-modulated 
chondrocytes were cultured for 7 d in the absence of RA, and 
in the absence (Fig. 2 e) and presence (Fig. 2 f) of 1 x  10  -6 
M  colchicine. 
Alterations in Intermediate Filament Organization 
The formation and organization of the intermediate filament 
cytoskeleton, although modulated by RA,  was not signifi- 
cantly affected by the addition of DHCB to the cultures. The 
formation of the well-developed and extensive intermediate 
filament network seen in control primary chondrocytes (Fig. 
3 a) was clearly suppressed in RA-modulated cells (Fig. 3 
b). The latter showed only faintly staining structures located 
near the nucleus. This is consistent with other studies, where 
vimentin synthesis and filament formation appeared to be 
responsive to changes in cell density and cell growth (3). 
Continued culture of RA-modulated chondrocytes for 7 d 
in the absence (Fig.  3 d) or presence of DHCB (Fig. 3 c) 
resulted in limited formation of condensed intermediate fila- 
ment structures, with only diffuse staining in the majority of 
cells.  No  further  alterations  in  intermediate  filament ar- 
chitecture were observed by 14 d. Again the specificity of in- 
termediate filament staining was demonstrated by treatment 
of the  cells  with  colchicine.  RA-modulated  chondrocytes 
were cultured for 2 d in the absence of RA, and in the ab- 
sence (Fig.  3  e) and presence (Fig.  3 f) of 1  ￿  10  -6 M 
colchicine. The perinuclear rings of fluorescence are charac- 
teristic of vimentin-containing intermediate filaments in col- 
chicine-treated cells (21). 
~me Course of  DHCB Effects on 
Microfilament Organization 
The rate of action of DHCB on microfilament organization 
was assessed in RA-modulated chondrocytes cultured in the 
absence of RA and in the presence of DHCB for 2, 24, and 
48 h. After 2 h the DHCB-treated cells had lost some inten- 
sity of staining and fiber definition (Fig. 4 b) when compared 
with RA-modulated chondrocytes cultured in the absence of 
both RA and DHCB (Fig. 4 a). After 24 h of DHCB treat- 
ment the characteristic pattern of stress fiber organization in- 
duced by RA was less detectable (Fig. 4 c), and had been lost 
completely by 48 h (Fig. 4 d). The RA-induced pattern was 
replaced  with parallel arrays  of condensed fibers aligned 
with the longitudinal axis of the cell and which appeared to 
be aligned with the same axis of neighboring cells. Changes 
after 48 h were less substantial, and the stress fiber organiza- 
tion after 7 and 14 d of DHCB treatment showed similar fea- 
tures. 
Effect of  Serum on Microfilament 
Modification by DHCB 
Analysis of the collagen phenotype of cells cultured with 
DHCB in medium containing low levels of FBS (1 and 2%), 
has revealed a complete lack of reexpression of the differen- 
tiated phenotype, indicating a requirement for some serum 
component (6). Therefore the effect of DHCB on microfila- 
ment architecture was examined during culture in 2 % FBS. 
The microfilament/stress fiber organization of these cells 
appeared equally affected by DHCB treatment.  After 2  d 
cells  cultured  in  the  absence of DHCB  still  retained the 
RA-induced stress fiber organization (Fig. 4 e), whilst those 
cultured in the presence of DHCB (Fig. 4 f) showed a pat- 
tern of stress fiber organization very similar to that seen in 
DHCB-treated cells cultured in medium containing 10% se- 
rum (Fig. 4 d). 
Discussion 
The immunofluorescent studies presented support the  in- 
volvement of microfilaments in the modulation of the chon- 
drocyte phenotype, these structures being modified initially 
by the presence of RA and again during reexpression of the 
differentiated phenotype by DHCB. In contrast the organiza- 
tion of microtubules was unaffected by either RA or DHCB 
treatment.  Similarly the organization of intermediate fila- 
ments,  although modulated by RA treatment,  was  largely 
unaffected by the presence of DHCB. The modifications in 
microfilament/stress fiber architecture induced by  DHCB 
occurred within 2 d and preceded both an increase in pro- 
teoglycan synthesis  and  reexpression  of type II  collagen 
which occurred after 4 and 6 d of DHCB treatment, respec- 
tively (6).  This  sequence of events and the  specificity of 
DHCB strongly support a causative role for microfilament 
modification in the reexpression of the differentiated chon- 
drocyte phenotype. The alterations in microfilament organi- 
zation in the absence of DHCB were less marked and more 
gradual, and resulted in the synthesis of 10-fold less type II 
collagen (6). Thus, loss of the RA-induced peripheral fila- 
ment morphology alone is an inadequate stimulus for reex- 
pression.  Clearly,  specific structural alterations caused by 
DHCB are required to free the cells from the residual aspects 
of the RA-induced phenotype. 
These specific alterations and the subsequent induction of 
reexpression occur in the absence of cell rounding or retrac- 
tion (6). This dissection of microfilament modification from 
the events of cell shape change emphasizes the importance 
of microfilament architecture in the mechanism of reexpres- 
sion and suggests that shape-dependent changes in chondro- 
cyte phenotypic expression are mediated by this mechanism. 
This is conceptually supported by a recent study in which it 
was demonstrated that the induction ofprocollagenase in cul- 
tured fibroblasts was dependent on microfilament disruption 
but could be independent of spherical morphology. The dis- 
section of these events was achieved by colchicine treatment 
of cells embedded in collagen which induced spherical mor- 
phology without significantly altering the cortical distribu- 
tion of microfilaments, and without inducing procollagenase 
synthesis (23). 
The present study also demonstrates that DHCB induces 
essentially identical microfilament rearrangements in both 2 
and 10 % FBS. This is important because significant DHCB- 
dependent reexpression is only observed in 10% serum (6). 
Thus, the failure of 2 % serum-treated cultures to reexpress 
is apparently due to the absence of a required serum factor 
rather than a deficit in the initial microfilament signal  for 
reexpression. 
In considering the modulatory effects of RA on the cyto- 
The Journal of Cell Biology, Volume  106, 1988  176 Figure 4. Fluorescent staining of actin-containing  microfilament  bundles in RA-modulated chondrocytes with rhodamine-labeled  phalloidin. 
Cells were cultured in the absence of RA and in the absence (a and e) and presence (b, c, d, and f) of DHCB for 2 (a, b, and e), 24 
(c), and 48 h (d and f).  Cells shown in (e) and (f) were cultured in medium containing 2%  FBS. Bar, 20 gm. 
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cytes it is important to note that the mechanism of action of 
this compound remains unclear.  The suppressive effect of 
RA treatment on the formation of intermediate filaments is 
probably a result of  the contact inhibition of  growth exhibited 
by these cells. Previous studies have shown vimentin synthe- 
sis and intermediate filament formation to be highly respon- 
sive to cell density in monolayer culture. Bovine epithelial 
cells grown in sparse monolayer culture contained an exten- 
sive intermediate filament network as detected by immuno- 
fluorescence, however the same cells grown in high-density 
monolayer culture contained only very limited intermediate 
filament structures (3).  Thus ceil-cell contact may directly 
suppress filament formation in RA-modulated chondrocytes. 
Control cells that do not exhibit contact inhibition of growth, 
and therefore may be generally less responsive to cell contact 
stimuli,  possess more extensive networks of intermediate 
filaments. 
The means by which RA is able to induce change in stress 
fiber organization may be related to its ability to modify the 
glycosylation  of  chondrocyte fibronectin, increasing the ratio 
of complex-type carbohydrate chains to high-mannose oligo- 
saccharides (8).  This represents a  shift towards fibroblast 
fibronectin,  which  contains  only complex-type  carbohy- 
drates and might explain the increased ability of RA-treated 
chondrocytes to bind fibronectin to their surfaces (11). This 
increased binding ability might in turn be expected to effect 
the complex relationship between actin, vinculin, fibronec- 
tin,  and  the fibronectin receptor  (10, 20)  resulting  in  in- 
creased regions of focal contact or adhesion plaques, hence 
causing a  reordering of the actin containing stress fibers. 
Such changes in cell adhesion/shape or microfilament orga- 
nization may subsequently contribute to the mechanism of 
phenotypic modulation. 
The  addition of fibroblast-derived fibronectin to  chick 
embryo chondrocyte cultures has been shown in previous 
studies to enhance cell adhesion and spreading, and increase 
the rate of phenotypic modulation (26).  This appears to be 
a specific effect of cellular fibronectin, because plasma fibro- 
nectin enhances adhesion without causing detectable modu- 
lation (25). Thus RA may be accelerating both the processes 
of cell adhesion and phenotypic modulation that occur more 
gradually during serial monolayer culture (7). Indeed it has 
been observed in the current study that RA-treated cells show 
enhanced adhesion in primary culture, However it should be 
noted that the pattern of stress fiber organization in these cul- 
tures is very different  from that seen in subculture-modulated 
chondrocytes, the latter consisting of very brightly staining 
fibers aligned in parallel and running throughout the cell (un- 
published observations). In addition important differences in 
collagen phenotype exist between these kinds of modulated 
chondrocytes (4). 
A more direct role for RA in phenotypic modulation has 
been proposed in a  recent report in which it was demon- 
strated that RA was able to modulate the phenotype of chick 
sternal chondrocytes maintained in a spherical conformation 
by culture in methyl cellulose (12). The authors conclude that 
RA exerts its modulatory effect in a direct manner,  inde- 
pendent of changes in cell shape or adhesion. The results 
presented here do not contradict this conclusion, and it is 
probable that in the current monolayer study, RA is operating 
through a combination of  direct and indirect effects. However 
the study by Horton and Hassell does not rule out the possi- 
bility that phenotypic influence is mediated by the binding 
of RA-modulated fibronectin to spherical chondrocytes. In- 
deed a role for microfilamentlsurface  fibronectin interactions 
in the modulation of the chondrocyte phenotype is supported 
by studies in which chondrogenesis of proximal limb bud 
cells in hydrated collagen gels was inhibited by fibronectin- 
containing gels (22),  and released from this inhibition by 
treatment with cytochalasin D (27). 
The effects of DHCB on cytoskeletal organization have 
been shown to be relatively specific; glucose transport being 
unaffected by concentrations of DHCB that caused marked 
changes in microfilament structures (2).  Other studies have 
demonstrated the ability of cytochalasins to inhibit or reduce 
the rate of actin polymerization and interfilament cross-link- 
ing (9,  15). It has also been reported that the disruption of 
microfilaments by cytochalasin B causes the release of fibro- 
nectin from the surface of cells in culture (1), presumably as 
a  result of the disruption of the actin-vinculin-fibronectin 
complexes that have been located at focal contact points in 
growth arrested cells (20). We have recently demonstrated by 
immunofluorescence that RA-modulated rabbit chondrocytes 
accumulate increased amounts of surface-bound fibronectin 
relative to control cells and that DHCB treatment results in 
a rapid loss of this bound fibronectin (unpublished observa- 
tions).  Thus DHCB treatment of R_A-modulated chondro- 
cytes can induce subtle changes in fibronectin distribution 
without inducing overt changes in cell shape. 
In furthering the understanding of these mechanisms of 
phenotypic regulation it will be important to discriminate be- 
tween changes in cell shape, cell adhesion, cell-cell contact, 
and cytoskeletal organization.  The results presented here 
have allowed some dissection to be made between the effects 
of cell shape and microfilament organization. Further analy- 
sis of the  sequence of changes following DHCB-induced 
microfilament modification, and the identification of the site 
of action of the required serum component should allow a 
better understanding of this mechanism of regulation and its 
biological significance. 
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